Avacta Group PLC | Income Statement

Fiscal year is August-July. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,700.00
1,618.00
1,813.00
2,165.00
2,735.00
2,763
Cost of Goods Sold (COGS) incl. D&A
1,187.00
774.00
1,011.00
2,141.00
2,524.00
2,927
Gross Income
1,513.00
844.00
802.00
24.00
211.00
164
SG&A Expense
3,386.00
2,657.00
3,962.00
5,688.00
8,181.00
9,284
EBIT
1,873.00
-
3,160.00
5,664.00
7,970.00
9,448
Unusual Expense
-
232.00
2,407.00
-
-
822
Non Operating Income/Expense
-
-
-
-
11.00
161
Pretax Income
1,852.00
2,021.00
5,541.00
5,565.00
7,893.00
10,390
Income Tax
331.00
551.00
648.00
918.00
1,526.00
1,561
Consolidated Net Income
1,521.00
1,470.00
4,893.00
4,647.00
6,367.00
8,829
Net Income
1,521.00
1,470.00
4,893.00
4,647.00
6,367.00
8,829
Net Income After Extraordinaries
1,521.00
1,448.00
205.00
4,647.00
6,367.00
8,829
Net Income Available to Common
1,521.00
1,492.00
10,139.00
4,647.00
6,367.00
8,829
EPS (Basic)
0.05
0.04
0.20
0.07
0.09
0.13
Basic Shares Outstanding
31,570.70
41,815.30
49,729.80
67,713.80
68,389.80
65,437
EPS (Diluted)
0.05
0.04
0.20
0.07
0.09
0.13
Diluted Shares Outstanding
31,570.70
41,815.30
49,729.80
67,713.80
68,389.80
65,437
EBITDA
1,506.00
1,566.00
2,675.00
4,418.00
6,387.00
7,414
Non-Operating Interest Income
21.00
24.00
26.00
99.00
88.00
41

About Avacta Group

View Profile
Address
Thorp Arch Estate
Leeds West Yorkshire LS23 7FA
United Kingdom
Employees -
Website http://avacta.com
Updated 07/08/2019
Avacta Group Plc engages in the provision of proprietary solutions to the healthcare sector. It operates through the Life Sciences and Animal Health segments. The Life Sciences segment offers custom Affimers for reagents and diagnostics, drug and biomarker discovery in biotech research and development.